Home / Sweden / Elicera Therapeutics AB
Elicera Therapeutics AB
No short position is open on this share today.
Evolution of the disclosed total
February 26, 2025 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Elicera Therapeutics AB by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 21, 2025 | Guevoura Fund | 1.20% | |
| March 10, 2025 | Guevoura Fund | 1.60% | |
| March 7, 2025 | Guevoura Fund | 1.57% | |
| March 6, 2025 | Guevoura Fund | 1.39% | |
| March 4, 2025 | Guevoura Fund | 1.04% | |
| March 3, 2025 | Guevoura Fund | 0.80% | |
| February 27, 2025 | Guevoura Fund | 0.61% | |
| February 26, 2025 | Guevoura Fund | 0.58% |
Download 8 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
- Elekta AB (publ) 8.98% of the capital sold short
- JM AB 7.61% of the capital sold short
- Truecaller AB 6.87% of the capital sold short
- Bonesupport Holding AB 6.80% of the capital sold short
- Hemnet Group AB (publ) 6.13% of the capital sold short
- RaySearch Laboratories AB (publ) 4.96% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Aktiebolaget Electrolux 4.41% of the capital sold short
- AAK AB (publ) 4.31% of the capital sold short
- Dynavox Group AB 3.88% of the capital sold short
- Hexatronic Group AB 3.69% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Elicera Therapeutics AB, source Finansinspektionen, data as at March 21, 2025, https://www.quivad.com/action/elicera-therapeutics-ab